Skip to main content
logo
Prelude Therapeutics Incorporated (PRLD)
NASDAQ: PRLD · Real-Time Price · USD
4.700
+0.300 (6.82%)
At close: Apr 24, 2026, 4:00 PM EDT
4.710
+0.010 (0.21%)
After-hours: Apr 24, 2026, 7:51 PM EDT

Prelude Therapeutics Revenue

In the year 2025, Prelude Therapeutics had annual revenue of $12.14M with 73.43% growth. Prelude Therapeutics had revenue of $5.64M in the quarter ending December 31, 2025, with 41.00% growth.

Revenue (ttm)
$12.14M
Revenue Growth
+73.43%
P/S Ratio
38.93
Revenue / Employee
$153,671
Employees
79
Market Cap
472.60M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202512.14M5.14M73.43%
Dec 31, 20247.00M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Valneva SE205.07M
REGENXBIO170.44M
Ginkgo Bioworks Holdings170.16M
4D Molecular Therapeutics85.21M
XOMA Royalty52.15M
Entrada Therapeutics25.42M
Armata Pharmaceuticals4.90M
Revenue Rankings

PRLD News

More News